- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
A prospective study of birth weight and prostate cancer risk and mortality in the Health Professionals Follow-up Study.
February 28, 2024
Pencil Beam Scanning Proton Bragg Peak Conformal FLASH in Prostate Cancer Stereotactic Body Radiotherapy.
February 28, 2024
Cancer cells employ lipid droplets to survive toxic stress.
February 28, 2024
One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer.
February 28, 2024
Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancer.
February 28, 2024
Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk.
February 28, 2024
Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.
February 27, 2024
Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING).
February 27, 2024
Diffuse Pneumonitis after Lutetium-177-PSMA-617 Treatment in a Patient with Metastatic Castration-Resistant Prostate Cancer.
February 27, 2024
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.
February 26, 2024
Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis.
February 26, 2024
Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications.
February 26, 2024
A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer.
February 26, 2024
Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5.
February 26, 2024